Sona Nanotech Inc. | Kin Communications

Sona Engages Sports Marketing Partner to Secure Concussion Test Development Part…

Vancouver, BC – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (“Sona Nanotech” or the “Company”), a developer of rapid, point-of-care diagnostic tests, announced today it has engaged Bonham/Wills & Associates … Read More

Sona Nanotech Announces Clinical Evaluation Study Results for its COVID-19 Antig…

Halifax, Nova Scotia – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (“Sona Nanotech” or the “Company”) a developer of rapid, point-of-care diagnostic tests, is pleased to announce that its rapid … Read More

Sona Nanotech Clinical In-Field Validation Study Results to Be Released Next Wee…

Halifax, Nova Scotia – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (“Sona Nanotech” or the “Company”), a developer of rapid, point-of-care diagnostic tests, announces that it expects to release a … Read More

Sona Nanotech Updates on Timing of Clinical In-Field Validation Studies for its …

Halifax, Nova Scotia – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (“Sona Nanotech” or the “Company”), a developer of rapid, point-of-care diagnostic tests, announces that its previously announced clinical, in-field … Read More

© Kin Communications 2020   |    Terms of Service   |   Privacy Policy